SBS Share Price

Open 18.00 Change Price %
High 19.00 1 Day -0.50 -2.78
Low 16.25 1 Week 0.00 0.00
Close 17.50 1 Month 0.00 0.00
Volume 53000 1 Year 2.90 19.86
52 Week High 19.00
52 Week Low 14.00
SBS Important Levels
Resistance 2 20.05
Resistance 1 19.00
Pivot 17.58
Support 1 16.00
Support 2 14.95
LON UK Most Active Stocks
LLOY 69.20 0.33%
HER 0.07 0.00%
HER 0.07 0.00%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
OEX 0.41 32.26%
OEX 0.41 32.26%
OEX 0.41 32.26%
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
LDP 0.03 50.00%
LDP 0.03 50.00%
OEX 0.41 32.26%
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%

Source BioScience PLC (LON: SBS)

SBS Technical Analysis 1.5
As on 15th Sep 2016 SBS Share Price closed @ 17.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 16.69 & Sell for SHORT-TERM with Stoploss of 17.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
SBS Target for April
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SBS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website
SBS Address
1 Orchard Place
Nottingham Business Park
Nottingham, NG8 6PX
United Kingdom
Phone: 44 11 5973 9012
SBS Latest News
Axios Pro Rata   Axios   - 27th Apr 17
John Kostrzewa: RI's pursuit of a life-sciences economy is a good bet   The Providence Journal   - 07th Apr 17
Biotech giant backed by Neil Woodford confirms £100m London float   City A.M.   - 02nd Feb 17
Aytu BioScience Strengthens Board with the Appointment of Two Pharmaceutical ...   PR Newswire (press release)   - 13th Jul 16
The week ahead in business and finance   - 06th Jun 16
Healthcare Analytical Testing Services Market Worth 4.13 Billion USD by 2021   PR Newswire (press release)   - 30th May 16
3 things you should know about Greater Washington's bioscience companies   Washington Business Journal (blog)   - 13th May 16
10 Notts companies in London Stock Exchange 'Inspire Britain' report   Nottingham Post   - 22nd Feb 16
Five stocks to cure your portfolio   Interactive Investor   - 25th Sep 15
Source BioScience opens new DNA sequencing facility in Tramore   Business Wire (press release)   - 03rd Feb 14
Interactive Technical Analysis Chart Source BioScience PLC ( SBS LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Source BioScience PLC
SBS Business Profile
Source BioScience plc provides diagnostics and genetic analysis services and products to healthcare and life science research markets primarily in the United Kingdom. The company operates in three segments: Healthcare, LifeSciences, and Stability and Bio Storage. The Healthcare segment offers diagnostics services, including diagnostic testing for cancer and other diseases; and cytology and serology products, such as cervical cancer screening and blood banking serology reagents. The LifeSciences segment provides DNA sequencing services and related products to academic research groups, and biotechnology and pharmaceutical companies through its network of laboratories and distributors. This segment offers GenomeCube, an e-commerce platform, database, and search engine that provides a portfolio of approximately 26 million cDNA clones and 120,000 antibodies; and reSource range of own branded products, primarily focused on the life science research work flow requirements for the DNA extraction and preparation. The Stability and Bio Storage segment provides drug discovery support services, such as biomarker discovery and clinical trial services, and stability storage and sample archiving under environmentally controlled conditions. In addition, the company is engaged in provision of diagnostic and genomic services; distribution of diagnostic and genomic products; and rental of properties. It also has operations in Europe, the Americas, the Middle East, Asia, and Australasia. The company was formerly known as Medical Solutions plc and changed its name to Source BioScience plc in March 2008. Source BioScience plc is headquartered in Nottingham, the United Kingdom.